Bidwell Health
Online Herpes Treatment — $45 Visit
Bidwell offers a $45 online visit for adults ages 18 and older with a prior herpes diagnosis who are seeking episodic or daily suppressive antiviral treatment. A licensed clinician reviews the interactive visit and sends a prescription to the patient's pharmacy only if clinically appropriate. Bidwell does not diagnose new herpes infections online, does not require photo upload, and does not guarantee treatment.
Who is this herpes visit for?
This visit is for adults who already know they have herpes and need help with ongoing care. That can mean oral herpes, often called cold sores, or genital herpes. Bidwell can review episodic treatment for outbreaks and daily suppressive therapy for patients trying to reduce recurrence frequency.
If you have never been diagnosed, have a new rash or sore, or need STI testing, this is not the right visit. You need in-person testing, a local sexual-health clinic, Planned Parenthood, a county health department, urgent care, or your primary care clinician.
How does the online visit work?
- Confirm you have a prior diagnosis.
- Choose oral cold sores or genital herpes.
- Choose current outbreak treatment, daily suppressive therapy, or both in one visit.
- Complete your interactive visit.
- A licensed clinician reviews your interactive visit and sends a prescription only if appropriate.
The visit is message-based and does not require a scheduled video call or photo upload.
What medications can Bidwell prescribe?
Bidwell may prescribe oral valacyclovir or acyclovir for eligible recurrent oral or genital herpes. Oral acyclovir for cold sores and daily suppression of cold sores are off-label uses. Famciclovir and topical acyclovir are not offered through this visit. Medication costs are separate from the $45 visit and paid at your pharmacy.
Common outbreak and daily treatment regimens
These are examples for immunocompetent adults with normal kidney function, not a prescription for an individual. Bidwell treats recurrent disease after a prior diagnosis, not first episodes. The clinician selects one appropriate regimen; do not combine alternatives or change the dose yourself.
| Purpose | Adult oral regimen | Source and limits |
|---|---|---|
| Cold-sore outbreak | Valacyclovir: 2 g twice in 1 day, about 12 hours apart | FDA-labeled cold-sore regimen. Two doses only; do not extend the course yourself. |
| Cold-sore outbreak | Acyclovir: 400 mg three times daily for 5 days (15 tablets) | Off-label oral use; Bidwell's approved option, also described in the cited AAFP review. |
| Recurrent genital outbreak | Valacyclovir: 500 mg twice daily for 3 days OR 1 g once daily for 5 days | Both are CDC recurrent-outbreak options offered by Bidwell. The 500 mg twice-daily, three-day course is also FDA-labeled. Your clinician selects one course. |
| Recurrent genital outbreak | Acyclovir: 800 mg twice daily for 5 days, OR 800 mg three times daily for 2 days | Two alternative CDC regimens. The clinician chooses one, not both. |
| Daily genital suppression | Valacyclovir: 500 mg once daily OR 1 g once daily | Bidwell usually starts with 500 mg daily when appropriate; 1 g daily is another clinician-selected option for frequent outbreaks. Tell your clinician how many outbreaks you have per year. CDC notes that 500 mg daily may be less effective with 10 or more outbreaks a year. |
| Daily genital suppression | Acyclovir: 400 mg twice daily | CDC and labeling support this regimen. Follow-up determines whether to continue. |
Sources: Valtrex prescribing information; CDC genital herpes guidance; AAFP oral herpes review (2010).
What is the difference between outbreak and suppressive treatment?
| Treatment type | Typical patient question | What it means |
|---|---|---|
| Episodic outbreak treatment | I have symptoms starting now. Can I treat this outbreak? | Short-course antiviral treatment started early in an outbreak. |
| Daily suppressive therapy | I keep getting outbreaks or want to reduce recurrence risk. Can I take medicine daily? | Daily antiviral treatment to reduce recurrences; a 90-day supply is not an automatic stopping point. |
When should I not use Bidwell for herpes?
- Get emergency care now for confusion, new weakness, or a severe headache with stiff neck, especially with fever. Call 911 if you cannot get there safely.
- Get urgent same-day assessment for eye pain, redness with light sensitivity or vision changes, sores near the eye, inability to urinate, severe pain, widespread sores, or fever with severe illness. Do not wait for an online prescription.
- Arrange in-person evaluation for a first possible outbreak, an uncertain or changed rash, significant immune suppression, or kidney disease needing individualized dosing. Pregnancy, possible pregnancy, and breastfeeding require care outside this Bidwell service; promptly contact your obstetric clinician for new genital symptoms.
Frequently asked questions
Can Bidwell diagnose herpes online?
No. Bidwell treats only adults who have already been diagnosed with herpes by a healthcare provider.
Do I need to upload a photo?
No. Bidwell does not use photo upload in the herpes flow. Prior diagnosis is required.
Can I choose daily suppressive therapy?
You can request it. A licensed clinician decides whether daily therapy is clinically appropriate after reviewing your interactive visit.
When should I get urgent help?
Get emergency care for confusion, new weakness, or severe headache with stiff neck, especially with fever; call 911 if you cannot get there safely. Eye symptoms, inability to urinate, severe pain, or fever with severe illness need urgent same-day care. First outbreaks need in-person evaluation, not this service.
How long does daily treatment continue?
A 90-day supply describes the amount dispensed, not an instruction to stop after 90 days. Continue according to your prescription. Authorized pharmacy refills do not require another visit. When those refills are exhausted and a new prescription is needed, renewal requires a new $45 visit. Included clinical follow-up messaging lasts 21 days; medication costs are separate. Contact your clinician sooner if your health or treatment goals change. There is no required subscription.
For recurrent genital HSV-2, CDC recommends discussing continued suppression at least yearly. A new safety concern, side effect, or change in symptoms can require earlier review.